Key Takeaways
- Indian scientists have discovered how cells decide between survival and self-destruction under stress.
- A protein called HRI acts as the central switch, pausing protein production and then choosing a path.
- The finding opens new doors for treating cancer, heart attacks, and neurodegenerative diseases.
In a landmark discovery, an Indian research team has decoded the precise molecular mechanism cells use to make critical life-or-death decisions during crises like oxygen or nutrient starvation. Published in Nature Communications, the study reveals how cells choose between a protective hibernation state and programmed self-destruction to safeguard the body.
The Central Decision-Maker: HRI Protein
The research, led by scientists from Bengaluru’s Institute for Stem Cell Science and Regenerative Medicine (inStem) and the National Centre for Biological Sciences (NCBS), zeroes in on a protein named HRI (heme-regulated inhibitor). Normally inactive, HRI springs into action during cellular stress.
Its first move is to halt the cell’s entire protein-making machinery, conserving precious energy—an emergency shutdown.
“Think of HRI as a foreman in a factory facing a power outage. His first action is to hit the emergency stop button on all assembly lines (protein synthesis) to save power and prevent the production of faulty products,” explained Dr. Ritesh Kumar, the lead author of the study.
Two Paths: Survival or Sacrifice
After the global pause, HRI’s sophisticated role unfolds. It selectively allows the production of specific stress-response proteins.
The Survival Path: HRI enables the production of protein ATF4, which activates genes that help the cell adapt and survive, pushing it into a low-energy ‘hibernation’ mode.
The Death Path: Simultaneously, HRI facilitates production of the CHOP protein, which can steer the cell toward apoptosis (programmed cell death) if the stress is too severe and irreversible.
“The cell is constantly weighing survival signals against death signals. HRI sits at the heart of this balance, integrating stress intensity and duration to guide the cell towards the most beneficial outcome for the entire organism,” said Prof. Ramanathan Sowdhamini, one of the senior investigators.
Implications for Treating Major Diseases
This discovery has major implications for medicine. Cells undergo similar stress in heart attacks, strokes, and within solid tumours.
- Cancer: Tumour cells often hijack the pro-survival ATF4 pathway to thrive in harsh, low-oxygen environments.
- Neurodegenerative Diseases: In conditions like Alzheimer’s, excessive activation of the cell death pathway may accelerate neuron loss.
The research, which used cryo-electron microscopy to visualize HRI’s structure, provides a clear target for future drugs.
“By understanding the precise molecular switches, we can potentially develop new therapies. For cancer, we could design drugs to block the pro-survival signal and sensitise tumours to treatment. For ischemic injuries, we could enhance the pro-survival signals to protect healthy tissue,” said Dr. Ritesh Kumar.
This entirely India-led study marks a significant leap in fundamental cell biology, paving the way for that could manipulate this cellular decision-making process to treat a range of severe diseases.
